278 related articles for article (PubMed ID: 29778502)
1. Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.
Okano T; Imai K; Tsujita Y; Mitsuiki N; Yoshida K; Kamae C; Honma K; Mitsui-Sekinaka K; Sekinaka Y; Kato T; Hanabusa K; Endo E; Takashima T; Hiroki H; Yeh TW; Tanaka K; Nagahori M; Tsuge I; Bando Y; Iwasaki F; Shikama Y; Inoue M; Kimoto T; Moriguchi N; Yuza Y; Kaneko T; Suzuki K; Matsubara T; Maruo Y; Kunitsu T; Waragai T; Sano H; Hashimoto Y; Tasaki K; Suzuki O; Shirakawa T; Kato M; Uchiyama T; Ishimura M; Tauchi T; Yagasaki H; Jou ST; Yu HH; Kanegane H; Kracker S; Durandy A; Kojima D; Muramatsu H; Wada T; Inoue Y; Takada H; Kojima S; Ogawa S; Ohara O; Nonoyama S; Morio T
J Allergy Clin Immunol; 2019 Jan; 143(1):266-275. PubMed ID: 29778502
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.
Coulter TI; Chandra A; Bacon CM; Babar J; Curtis J; Screaton N; Goodlad JR; Farmer G; Steele CL; Leahy TR; Doffinger R; Baxendale H; Bernatoniene J; Edgar JD; Longhurst HJ; Ehl S; Speckmann C; Grimbacher B; Sediva A; Milota T; Faust SN; Williams AP; Hayman G; Kucuk ZY; Hague R; French P; Brooker R; Forsyth P; Herriot R; Cancrini C; Palma P; Ariganello P; Conlon N; Feighery C; Gavin PJ; Jones A; Imai K; Ibrahim MA; Markelj G; Abinun M; Rieux-Laucat F; Latour S; Pellier I; Fischer A; Touzot F; Casanova JL; Durandy A; Burns SO; Savic S; Kumararatne DS; Moshous D; Kracker S; Vanhaesebroeck B; Okkenhaug K; Picard C; Nejentsev S; Condliffe AM; Cant AJ
J Allergy Clin Immunol; 2017 Feb; 139(2):597-606.e4. PubMed ID: 27555459
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.
Condliffe AM; Chandra A
Front Immunol; 2018; 9():338. PubMed ID: 29556229
[TBL] [Abstract][Full Text] [Related]
4. Successful haploidentical hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase δ syndrome: Case report and literature review.
Yang X; Xi R; Bai J; Pan Y
Medicine (Baltimore); 2023 Feb; 102(5):e32816. PubMed ID: 36749229
[TBL] [Abstract][Full Text] [Related]
5. Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.
Jamee M; Moniri S; Zaki-Dizaji M; Olbrich P; Yazdani R; Jadidi-Niaragh F; Aghamahdi F; Abolhassani H; Condliffe AM; Aghamohammadi A; Azizi G
Clin Rev Allergy Immunol; 2020 Dec; 59(3):323-333. PubMed ID: 31111319
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.
Elkaim E; Neven B; Bruneau J; Mitsui-Sekinaka K; Stanislas A; Heurtier L; Lucas CL; Matthews H; Deau MC; Sharapova S; Curtis J; Reichenbach J; Glastre C; Parry DA; Arumugakani G; McDermott E; Kilic SS; Yamashita M; Moshous D; Lamrini H; Otremba B; Gennery A; Coulter T; Quinti I; Stephan JL; Lougaris V; Brodszki N; Barlogis V; Asano T; Galicier L; Boutboul D; Nonoyama S; Cant A; Imai K; Picard C; Nejentsev S; Molina TJ; Lenardo M; Savic S; Cavazzana M; Fischer A; Durandy A; Kracker S
J Allergy Clin Immunol; 2016 Jul; 138(1):210-218.e9. PubMed ID: 27221134
[TBL] [Abstract][Full Text] [Related]
7. The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).
Fekrvand S; Delavari S; Chavoshzadeh Z; Sherkat R; Mahdaviani SA; Sadeghi Shabestari M; Azizi G; Arzanian MT; Shahin Shamsian B; Eskandarzadeh S; Eslami N; Rae W; Condino-Neto A; Mohammadi J; Abolhassani H; Yazdani R; Aghamohammadi A
Immunol Invest; 2022 Apr; 51(3):644-659. PubMed ID: 33401995
[TBL] [Abstract][Full Text] [Related]
8. Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome.
Wang Y; Wang W; Liu L; Hou J; Ying W; Hui X; Zhou Q; Liu D; Yao H; Sun J; Wang X
J Clin Immunol; 2018 Nov; 38(8):854-863. PubMed ID: 30499059
[TBL] [Abstract][Full Text] [Related]
9. Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.
Asano T; Okada S; Tsumura M; Yeh TW; Mitsui-Sekinaka K; Tsujita Y; Ichinose Y; Shimada A; Hashimoto K; Wada T; Imai K; Ohara O; Morio T; Nonoyama S; Kobayashi M
Front Immunol; 2018; 9():568. PubMed ID: 29675019
[TBL] [Abstract][Full Text] [Related]
10. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome.
Dimitrova D; Nademi Z; Maccari ME; Ehl S; Uzel G; Tomoda T; Okano T; Imai K; Carpenter B; Ip W; Rao K; Worth AJJ; Laberko A; Mukhina A; Néven B; Moshous D; Speckmann C; Warnatz K; Wehr C; Abolhassani H; Aghamohammadi A; Bleesing JJ; Dara J; Dvorak CC; Ghosh S; Kang HJ; Markelj G; Modi A; Bayer DK; Notarangelo LD; Schulz A; Garcia-Prat M; Soler-Palacín P; Karakükcü M; Yilmaz E; Gambineri E; Menconi M; Masmas TN; Holm M; Bonfim C; Prando C; Hughes S; Jolles S; Morris EC; Kapoor N; Koltan S; Paneesha S; Steward C; Wynn R; Duffner U; Gennery AR; Lankester AC; Slatter M; Kanakry JA
J Allergy Clin Immunol; 2022 Jan; 149(1):410-421.e7. PubMed ID: 34033842
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase δ syndrome.
Luo Y; Xia Y; Wang W; Li Z; Jin Y; Gong Y; He T; Li Q; Li C; Yang J
Clin Immunol; 2018 Dec; 197():60-67. PubMed ID: 30138677
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.
Aydin SE; Freeman AF; Al-Herz W; Al-Mousa HA; Arnaout RK; Aydin RC; Barlogis V; Belohradsky BH; Bonfim C; Bredius RG; Chu JI; Ciocarlie OC; Doğu F; Gaspar HB; Geha RS; Gennery AR; Hauck F; Hawwari A; Hickstein DD; Hoenig M; Ikinciogullari A; Klein C; Kumar A; Ifversen MRS; Matthes S; Metin A; Neven B; Pai SY; Parikh SH; Picard C; Renner ED; Sanal Ö; Schulz AS; Schuster F; Shah NN; Shereck EB; Slatter MA; Su HC; van Montfrans J; Woessmann W; Ziegler JB; Albert MH;
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):848-855. PubMed ID: 30391550
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.
Ono S; Okano T; Hoshino A; Yanagimachi M; Hamamoto K; Nakazawa Y; Imamura T; Onuma M; Niizuma H; Sasahara Y; Tsujimoto H; Wada T; Kunisaki R; Takagi M; Imai K; Morio T; Kanegane H
J Clin Immunol; 2017 Jan; 37(1):85-91. PubMed ID: 27815752
[TBL] [Abstract][Full Text] [Related]
14. Activated Phosphoinositide 3-Kinase δ Syndrome: a Large Pediatric Cohort from a Single Center in China.
Qiu L; Wang Y; Tang W; Yang Q; Zeng T; Chen J; Chen X; Zhang L; Zhou L; Zhang Z; An Y; Tang X; Zhao X
J Clin Immunol; 2022 May; 42(4):837-850. PubMed ID: 35296988
[TBL] [Abstract][Full Text] [Related]
15. Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria.
Benakli M; Ahmed Nacer R; Mehdid F; Belhadj R; Talbi A; Rahmoune N; Niederwieser C; Baazizi M; Akhrouf S; Ait Ouali D; Bouarab H; Zerkout S; Abderahim I; Harieche F; Hamladji RM
Ann Hematol; 2020 Mar; 99(3):619-625. PubMed ID: 31974679
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of mortality and survival rates for APDS.
Hanson J; Bonnen PE
Clin Exp Med; 2024 Jan; 24(1):17. PubMed ID: 38280023
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team.
Tsuji Y; Imai K; Kajiwara M; Aoki Y; Isoda T; Tomizawa D; Imai M; Ito S; Maeda H; Minegishi Y; Ohkawa H; Yata J; Sasaki N; Kogawa K; Nagasawa M; Morio T; Nonoyama S; Mizutani S
Bone Marrow Transplant; 2006 Mar; 37(5):469-77. PubMed ID: 16435016
[TBL] [Abstract][Full Text] [Related]
18. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study.
Touzot F; Neven B; Dal-Cortivo L; Gabrion A; Moshous D; Cros G; Chomton M; Luby JM; Terniaux B; Magalon J; Picard C; Blanche S; Fischer A; Cavazzana M
J Allergy Clin Immunol; 2015 May; 135(5):1303-9.e1-3. PubMed ID: 25282016
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic cell transplantation in primary immunodeficiency - conventional and emerging indications.
Slatter MA; Gennery AR
Expert Rev Clin Immunol; 2018 Feb; 14(2):103-114. PubMed ID: 29300535
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies: 3 Decades of Experience From a Tertiary Medical Center.
Rousso SZ; Shamriz O; Zilkha A; Braun J; Averbuch D; Or R; Weintraub M; Revel-Vilk S; Stepensky P
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e295-300. PubMed ID: 25985240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
